CHARLOTTE, N.C. — Respiratory Syncytial Virus can be extremely dangerous for infants. But a shot that helps babies fight off RSV is currently in low supply.

The U.S. Centers for Disease Control and Prevention just issued a Health Alert Network Health Advisory, warning about a limited supply of nirsevimab. The monoclonal antibody shot helps protect infants during RSV season. 

The CDC provided recommendations for health care providers and families amid the availability of nirsevimab being limited. 

Part of the guidance includes prioritizing available nirsevimab 100mg doses for infants at highest risk for severe RSV. 

Dr. Amra Zuzo is a pediatrician with Novant Health pediatrics. 

Many of her patients are babies. 

Lately, Zuzo says there’s been lots of conversations with parents wanting to protect their babies from RSV, especially after learning about a limited supply of the shot. 

She says their concerns are top priority for Novant Health. 

“We have met as a pediatric community,” Zuzo said. “We have placed orders and are waiting for the second part of that process, which is actually getting it to our patients.”

Zuzo echoes the CDC recommendations for families whose infants need the shot.

“If they have not received it, I recommend they contact their local pediatrician and talk about when we’re actually expecting it to be delivered. If they’re not able to get it, we definitely want to make sure they decrease their chance of picking up the virus [such as] exposing them to crowds,” Zuzo said. 

Additional CDC recommendations for expectant parents include talking with your health care provider about receiving the RSV vaccine during pregnancy to protect your infant from severe RSV.